BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26913915)

  • 1. Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: a rare disease entity.
    Gupta A; Tse L
    N Z Med J; 2015 Dec; 128(1426):110-2. PubMed ID: 26913915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diarrhea caused by Campylobacter in patients with hematologic diseases].
    Fischer W; Gościniak G; Gałazka Z
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):131-2. PubMed ID: 1437800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2 cases of successful treatment of gastric lymphoma by means of polychemotherapy].
    Borisov VI; Korobkova LI; Vashakmadze LA; Frank GA
    Sov Med; 1984; (3):118-9. PubMed ID: 6547007
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study.
    De Angelis F; Tosti ME; Capria S; Russo E; D'Elia GM; Annechini G; Stefanizzi C; Foà R; Pulsoni A
    Leuk Res; 2015 Dec; 39(12):1382-8. PubMed ID: 26547259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cholecystitis caused by Campylobacter jejuni.
    Landau Z; Agmon NL; Argas D; Arcavi L; Simon D; Miskin A
    Isr J Med Sci; 1995 Nov; 31(11):696-7. PubMed ID: 7591706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab.
    Hiraishi Y; Iikura M; Kogure Y; Hirashima J; Izumi S; Sugiyama H
    Respir Investig; 2014 Mar; 52(2):144-6. PubMed ID: 24636271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unusual cause of non-lithiasic acute cholecystitis: campylobacter jejuni].
    Taziaux P; Wahlen C; Drion S
    J Chir (Paris); 1991 Dec; 128(12):554-5. PubMed ID: 1809764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute cholecystitis caused by Campylobacter jejuni].
    Lepe JA; Guadalajara J
    Enferm Infecc Microbiol Clin; 1994; 12(7):364-5. PubMed ID: 7948125
    [No Abstract]   [Full Text] [Related]  

  • 9. CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.
    Czuczman MS
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):88-96. PubMed ID: 10561023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy and rituximab.
    Czuczman MS
    Anticancer Drugs; 2001 Jun; 12 Suppl 2():S15-9. PubMed ID: 11508932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid.
    Jonak C; Troch M; Müllauer L; Niederle B; Hoffmann M; Raderer M
    Thyroid; 2010 Apr; 20(4):425-7. PubMed ID: 20210673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
    Korman DB; Snimshchikov VA
    Vopr Onkol; 1992; 38(7):859-61. PubMed ID: 1300793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
    Nakayama S; Yabe H; Nagai K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2179-82. PubMed ID: 1888191
    [No Abstract]   [Full Text] [Related]  

  • 15. Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP.
    Pettengell R; Silvestre AS; Schwenkglenks M; Rossi FG; Duehrsen U; Verhoef G; Lugtenburg PJ; Wheeler T; Pujol B; Haioun C
    Hematology; 2013 Jan; 18(1):26-9. PubMed ID: 22980138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
    Sonneveld P
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):29-31. PubMed ID: 7863349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma].
    Hiruma K; Asai T; Aotsuka N; Hirasawa A; Wakita H; Endoh N; Nakamura H; Oh H; Yoshida S; Igarashi T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):59-64. PubMed ID: 1688699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
    Mantzios G; Tsirigotis P; Veliou F; Boutsikakis I; Petraki L; Kolovos J; Papageorgiou S; Robos Y
    Ann Hematol; 2004 Jul; 83(7):460-3. PubMed ID: 14730391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
    Takagi T; Sakai C; Oguro M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.